US 11723873
Oral dosage form of ticagrelor and preparation method thereof
granted A61KA61K31/519A61K47/10
Quick answer
US patent 11723873 (Oral dosage form of ticagrelor and preparation method thereof) held by Elite Pharmaceutical Solution Inc. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Elite Pharmaceutical Solution Inc.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/519, A61K47/10, A61K9/0004, A61K9/0053